Our mission is to design, develop, manufacture, and market proprietary, advanced, and affordable technologies that significantly improve quality of life by improving some of the most essential physiological functions in the body.
D’OXYVA biotechnology provides an inexpensive and simple method of solving the longstanding problem of delivering medication to the bloodstream through needles, which are highly invasive, or oral delivery, which often results in gastrointestinal (GI) tract absorption issues and loss of most of the active ingredients in medication.
It only takes an average of 5 minutes per application.
WHAT IT DOES?D’OXYVA (deoxyhemoglobin vasodilator) is the only fully non-invasive, non-irritating, non-opioid, and completely painless, skin delivery (over-the-skin) microcirculatory solution.With over five years of industry-leading clinical research results, D’OXYVA demonstrated that it does not break the skin’s barrier while it provides outsized quality of life and clinical outcomes quickly and affordably.In short, based on current leading neurology, immunology, microvascular, and cellular oxygenation science, D’OXYVA is leading the field by:Significantly lowering the risk of diabetes and cardiovascular complications.Providing complete improve of difficult wounds together with major pain relief and improved quality of life.
HOW IT WORKS?
D’OXYVA‘s gentle vapor solution with purified medical CO2 readily dissolves in a molecular form in the skin, acting as a catalyst to improve skin perfusion pressure and optimize nerve functions and microcirculation.
Non-electrical, handheld, painless
Fast & easy use virtually anywhere
GENERALLY RECOMMENDED BY DOCTORS TO BE USED
5 MINUTES / DAY—5 TIMES / WEEK
ACHIEVE—SAVE WITH D’OXYVA®
Take it daily—in a few weeks significantly reduce the risks of:
Chronic diabetic & vascular, burn, trauma wounds
Type 1 & 2 diabetes
Chronic venus insufficiency, varicose veins
High blood pressure, stroke, hypertension
MEASURE / FEEL / SEE RESULTS IN 5 WEEKS**
Over two dozen clinical studies demonstrated outsized results at clinics and at home with zero adverse events. For example, D’OXYVA® (deoxyhemoglobin vasodilator) has been recording significant results also as a varicose vein solution while delivering major clinical outcomes for well over 90% of users. Average results rounded for display, based on number of enrolled subjects in each clinical study with D’OXYVA and user feedback.
Read D’OXYVA Clinical Evidence >>
Ask your doctor before taking D’OXYVA. For prescription for medical use. Read D’OXYVA Regulatory Statements >>